Status:
UNKNOWN
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
Lead Sponsor:
Bedaya Hospital
Conditions:
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
PHASE2
Brief Summary
The aim of this study is to compare the efficacy double trigger \[ co-administration of GnRH agonist with HCG 40 and 34 h prior to ovum pick-up, respectively\] with HCG trigger in inducing oocyte matu...
Detailed Description
Several studies revealed that the double trigger regimen was effective in the treatment of patients with a history of immature oocytes retrieved or with suboptimal oocytes yield. The investigators de...
Eligibility Criteria
Inclusion
- Normoresponders
- GnRH antagonist cycles
Exclusion
- BMI more than 35
- Endometriosis
- AMH less than 1.1 ng
- AMH more than 4
- PCOS
- Poor responders
Key Trial Info
Start Date :
December 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06146413
Start Date
December 30 2023
End Date
December 30 2025
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bedaya Hospital
Giza, Egypt